Company Search:
Advanced Search
Sponsored Links
Synmosa Biopharma Corp Company Snapshot
Synmosa Biopharma Corp operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Synmosa Biopharma Corp with three other companies in this sector in TAIWAN : Formosa Laboratories, Inc (2019 sales of 2.76 billion Taiwanese Dollars [US$94.35 million] of which 100% was Active Pharmaceutical Ingredient), Sinphar Pharmaceutical C O., Ltd. (2.39 billion Taiwanese Dollars [US$81.87 million] of which 69% was Medicine), and Nang Kuang Pharmaceutical Co Ltd (1.76 billion Taiwanese Dollars [US$60.25 million] of which 100% was Medice, Medical Instrument, Trade).

Sales Analysis. Synmosa Biopharma Corp reported sales of 2.68 billion Taiwanese Dollars (US$91.63 million) for the year ending December of 2019. This represents an increase of 13.4% versus 2018, when the company's sales were 2.36 billion Taiwanese Dollars . Sales of Generic Drugs saw an increase of 13.9% in 2019, from 2.22 billion Taiwanese Dollars to 2.53 billion Taiwanese Dollars .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Synmosa Biopharma Corp
  Stock Performance Chart for Synmosa Biopharma Corp
  Stock Data: Recent Stock Performance:
  Current Price (9/11/2020): 25.90
(Figures in Taiwanese Dollars )
1 Week -0.8%   13 Weeks -3.7%  
4 Weeks 19.9%   52 Weeks 8.8%  
Synmosa Biopharma Corp Key Data:
  Ticker: 4114 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 2,679,966,000
(Year Ending Jan 2020).
Employees: 419
  Currency: Taiwanese Dollars Market Cap: 6,447,590,901
  Fiscal Yr Ends: December Shares Outstanding: 248,941,734
  Share Type: Gu Closely Held Shares: 84,632,847
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.